Millrace Asset Group’s SkinHealth Systems SKIN Stock Holding History

Millrace Asset Group’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-54,668	Closed	-$918K	–	79
2021 Q2	$918K	Sell	54,668 -271,049	-83%	-$3.71M	0.48%	78
2021 Q1	$3.52M	Buy	+325,717	New	+$3.58M	1.89%	7

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Millrace Asset Group's SKIN Position: Q3 2021 in Review

Millrace Asset Group sold out of SkinHealth Systems (SKIN) in Q3 2021, closing a stake of 54,668 shares — an estimated $918K sold.

Millrace Asset Group first reported a position in SKIN in Q1 2021 and held it in 2 quarters. The position peaked at $3.52M in Q1 2021. 165 funds tracked by Wall St. Rank hold SKIN as of Q3 2021.

Millrace Asset Group reported no remaining SkinHealth Systems position as of Q3 2021 after selling out during the quarter.
Millrace Asset Group sold 54,668 SkinHealth Systems shares in Q3 2021, an estimated $918K.
Millrace Asset Group first reported a position in SkinHealth Systems in Q1 2021 and held it in 2 quarters.
Millrace Asset Group's SkinHealth Systems position peaked at $3.52M in Q1 2021.
165 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2021.

Based on Millrace Asset Group's 13F filing for Q3 2021, filed 12 Nov 2021.